Hjem › Steatotisk leversykdom › Texas › Austin
Kliniske studier for Steatotisk leversykdom i Austin, TX
13 studier for Steatotisk leversykdom søker deltakere på steder i og rundt Austin (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 3
- GSK Investigational Site, Austin
A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 3
- GSK Investigational Site, Austin
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
RekruttererFase 2
- American Research Corporation, Austin
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RekruttererFase 2
- American Research Corporation, Austin
- Pinnacle Clinical Research - Austin, Austin
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RekruttererFase 3
- IMA Clinical Research Austin, Austin
- American Research Corporation, Austin
- Pinnacle Clinical Research, Austin
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekruttererFase 3
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
- Akero Clinical Study Site, Austin
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 2
- Pinnacle Clinical Research, Austin
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekruttererFase 3
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekruttererFase 3
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RekruttererFase 2
- GSK Investigational Site, Austin
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RekruttererFase 2
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
- GSK Investigational Site, Austin
Steatotisk leversykdom-studier i andre byer
- San Antonio, TX17 studier
- New York City, NY16 studier
- Miami, FL16 studier
- San Diego, CA14 studier
- Houston, TX13 studier
- Richmond, VA12 studier
- Chandler, AZ10 studier
- Tucson, AZ10 studier
- Orlando, FL9 studier
- Hialeah, FL9 studier
- St. Louis, MO9 studier
- Dallas, TX9 studier
Andre studier i Austin
- Ikke-småcellet lungekreft30 studier
- Kreft (alle typer)20 studier
- Fedme20 studier
- Metastatisk kreft19 studier
- Kolorektal kreft19 studier
- Hjertesvikt18 studier
- Brystkreft18 studier
- Overvekt18 studier
- Eggstokkreft17 studier
- Endometriekreft15 studier
- Prostatakreft15 studier
- Depresjon14 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.